Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2012
|
| In: |
Investigational new drugs
Year: 2011, Jahrgang: 30, Heft: 4, Pages: 1750-1755 |
| ISSN: | 1573-0646 |
| DOI: | 10.1007/s10637-011-9688-3 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1007/s10637-011-9688-3 Verlag, Volltext: https://link.springer.com/article/10.1007/s10637-011-9688-3 
|
| Verfasserangaben: | Sarah Schott, Markus Wallwiener, Beate Kootz, Harald Seeger, Tanja Fehm, Hans Neubauer |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 158005871X | ||
| 003 | DE-627 | ||
| 005 | 20230427065641.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180815r20122011xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10637-011-9688-3 |2 doi | |
| 035 | |a (DE-627)158005871X | ||
| 035 | |a (DE-576)51005871X | ||
| 035 | |a (DE-599)BSZ51005871X | ||
| 035 | |a (OCoLC)1341016623 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schott, Sarah |d 1981- |e VerfasserIn |0 (DE-588)133730816 |0 (DE-627)552697281 |0 (DE-576)27460678X |4 aut | |
| 245 | 1 | 0 | |a Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay |c Sarah Schott, Markus Wallwiener, Beate Kootz, Harald Seeger, Tanja Fehm, Hans Neubauer |
| 264 | 1 | |c 2012 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online: 21 May 2011 | ||
| 500 | |a Gesehen am 15.08.2018 | ||
| 534 | |c 2011 | ||
| 700 | 1 | |a Wallwiener, Markus |d 1980- |e VerfasserIn |0 (DE-588)134044827 |0 (DE-627)692043934 |0 (DE-576)27468327X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Investigational new drugs |d Dordrecht [u.a.] : Springer Science + Business Media B.V, 1983 |g 30(2012), 4, Seite 1750-1755 |h Online-Ressource |w (DE-627)320481492 |w (DE-600)2009846-7 |w (DE-576)121191028 |x 1573-0646 |7 nnas |a Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay |
| 773 | 1 | 8 | |g volume:30 |g year:2012 |g number:4 |g pages:1750-1755 |g extent:6 |a Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10637-011-9688-3 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s10637-011-9688-3 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180815 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 134044827 |a Wallwiener, Markus |m 134044827:Wallwiener, Markus |d 910000 |d 910400 |e 910000PW134044827 |e 910400PW134044827 |k 0/910000/ |k 1/910000/910400/ |p 2 | ||
| 998 | |g 133730816 |a Schott, Sarah |m 133730816:Schott, Sarah |d 910000 |d 910400 |e 910000PS133730816 |e 910400PS133730816 |k 0/910000/ |k 1/910000/910400/ |p 1 |x j | ||
| 999 | |a KXP-PPN158005871X |e 3022383924 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"role":"aut","family":"Schott","display":"Schott, Sarah","given":"Sarah"},{"display":"Wallwiener, Markus","given":"Markus","family":"Wallwiener","role":"aut"}],"recId":"158005871X","note":["Published online: 21 May 2011","Gesehen am 15.08.2018"],"name":{"displayForm":["Sarah Schott, Markus Wallwiener, Beate Kootz, Harald Seeger, Tanja Fehm, Hans Neubauer"]},"language":["eng"],"relHost":[{"title":[{"subtitle":"an interdisciplinary journal for clinicians and scientists","title":"Investigational new drugs","title_sort":"Investigational new drugs"}],"id":{"issn":["1573-0646"],"eki":["320481492"],"zdb":["2009846-7"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Dordrecht [u.a.] ; Dordrecht [u.a.]","dateIssuedKey":"1983","dateIssuedDisp":"1983-","publisher":"Springer Science + Business Media B.V ; Kluwer"}],"recId":"320481492","disp":"Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assayInvestigational new drugs","type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"part":{"issue":"4","extent":"6","pages":"1750-1755","text":"30(2012), 4, Seite 1750-1755","year":"2012","volume":"30"},"pubHistory":["1.1983 -"],"note":["Gesehen am 17.10.05","Fortsetzung der Druck-Ausgabe"]}],"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"2012"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay","title":"Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay"}],"physDesc":[{"extent":"6 S."}],"id":{"eki":["158005871X"],"doi":["10.1007/s10637-011-9688-3"]}} | ||
| SRT | |a SCHOTTSARACYTOTOXICI2012 | ||